Embed Size (px)
Citation preview
Sensor100The International Bio-sensor and Chemo-sensor Network
NewsletterAugust 2013
© 2013 Captum Capital Limited
Smartphone based artifical pancreasImage: Copyright American Diabetes Association
Contents
From the Editor 3
Sweden Promotes Digital Health 4
Coming Events 6
Call for Papers 7
Biosensors 2014 8
Quiz 9
Sensors in Medicine 2014 10
Nokia X-Challenge Finalists 12
Company News 14
Technology News 16
Diagnostics for Stratification Catapult 18
About Sensor100 19
www.sensor100.com
As summer draws to a close, and vacations quickly become distant memories, so the conference season kicks into gear again. Septem-ber is always full, with a slow decline up to the end of November. Most conference organisers consider the season is dead by the first week in December, but this year the 4th International Conference on Nanotechnology and Biosensors in Paris, France will be held on 20 - 21 December. I’ve never been in Paris in December, so perhaps near to Christmas it is a magical place. I have been to a Christmas market in Nuremberg, and with snow falling it was like something in a fairy tale.
For the next six months, we will be working hard on developing Sensors in Medicine 2014. Expect to hear from us on a fairly fre-quent basis - we are actively soliciting papers, poster, exhibitors and will open for delegate registration in September. Early bird discounts until 31 December. In 2014 the conference will move to the Royal Geographic Society conference centre in South Kensington, partly because the Wellcome Collection is closed for renovation, but more importantly because we can accommodate more exhibitors and delegates,
Look forward to seeing you next year, if not before.
Kind regards
From the editor...
Digital Health Days was a two-day event held at Stock-holmsmässan on 21 and 22 August 2013 and was attend-ed by HRH Prince Daniel and the Mayor of Stockholm. The event was organised by Stockholm Science City and chaired by the serial entre-preneur, Ola Ahlvarsson. It comprised a series of short seminars, panel discussions and hands-on demonstrations and explored the burgeoning interface between sen-sors, mobile communications, apps and self care.
The plenary speakers, including Anthony Turner from the Biosen-sors and Bioelectronics Centre at LiU, painted a picture of the future where aids to the maintenance of wellbeing are available 24/7 via mobile phones and other portable devices. The presenters were united in their vision of a future where healthcare, advice and treatment are delivered personally, in an individually tailored fashion, at home, in the workplace or anywhere at your convenience. This future vision will demand a complete restructuring of the current national systems and will be driven by the consumers. Governments and insurers will focus increasingly on outcomes with evidence-based reimbursement, while patients will have the opportunity to use and supplement their per-sonal healthcare records with online commercial products to deliver the comprehensive care and support they deserve.
One speaker, Sara Riggare, spoke powerfully about patient empow-erment. A Parkinson’s Disease sufferer, she talked of the time when she can have 8 760 hours of support per year to manage her disease instead of the 2 hours she currently gets from state healthcare.
Sweden Promotes Digital Health
HRH Prince Daniel in the audience
Biosensors were seen as the key to unlocking the biochemical in-formation necessary to enable this vision and must be effectively interfaced with mobile information technology. Such decentralised diagnostics will completely change the current paradigm. Ola Ahlvars-son suggested that in the not too distant future, we will laugh at how foolish we were to take time off work to stand in line at a hospital for diagnostic tests and then to have to go back another day to find out what treatment might be suitable.
Contributed by:Professor Anthony P. F. TurnerHead of the Biosensors & Bioelectronics CentreIFM, Linköping [email protected]
...Continued
Professor Turner being received by the Mayor of Stockholm, Sten Nordin,
in the City Hall
Electrochem 20131 - 3 September 2013, Southampton, UK
10th International Electrochemistry Meeting4 - 8 September, Konya, Turkey
64th Annual Meeting of the International Society for Electrochemistry 8 - 13 September, Santiago de Queretaro, Mexico
Microarray World Congress Single Cell Analysis Summit Point of Care Diagnostics World Congress Lab-on-a-Chip World Congress Co-located: 12 - 13 September, San Diego CA USA
Coming Events
224th Electrochemical Society Meeting 27 October - 1 November, San Francisco, CA USA
6th International Workshop on Surface Modification for Chemical and Biochemical Sensing 8 - 12 November, Łochów, Poland
Medica 20 - 23 November, Düssledorf, DE
EUROPT(R)ODE XII Conference on Optical Chemical Sensors and Biosensors13 - 16 April 2014, Athens GreeceAbstract Submission Deadline November 18, 2013
5th International Workshop on Intelligent Environ-ments Supporting Healthcare and Well-being (WISH-Well’13)3 December, Dublin IrelandPaper Submission Deadline 1 September 2013
2013 4th International Conference on Nanotechnol-ogy and Biosensors20 - 21 December, Paris FrancePaper submission deadline 25 September
Call for Papers
A short quiz:
1 Would you like to come for free?2 Are you a post-grad or post-doc?3 Try your hand at science journalism?
Yes to all of them? Maybe we can help each other.
Sensor100 invites short (200-400 word) ar�cles on sensor technology.
We’re looking for descrip�ons of how sensors work: background, technology and applica�ons, plus one or more images.Doesn’t have to be original - but it must be copy-right free, and not infringe confiden�ality.Can be old and trusted technology: ISEs, ChemFETs etc or more modern stuff: SERS, impedance etc.Interested? Contact us at
The Conference - Note the Date: 25 & 26 March 2014
Building on the success of the inaugural Sensors in Medicine 2013, this international conference will uniquely focus on the rapidly growing market for biosensors in medical diagnostics. The objectives of the conference are to:
Promote innovative new commercial sensor technology
Highlight leading academic research near to commercial use
Provide a platform for emerging sensor companies
Explore trends in medical applications of sensor technology
Facilitate formation of partnerships for investment and technology transfer
The Program
The Conference will feature:
Invited leading expert speakers from academia and industry
Contributed presentations on the Conference topics
Exhibits of new technology, emerging companies, service providers
Poster exhibits of innovations in medical sensor applications
Elevator pitches from emerging companies
A networking reception featuring this year’s Conference Cocktail
Sensors in Medicine 2014 is organised by Sensor100www.sensor100.com
Call for Papers - Deadline 31 December 2013
Topics relevant to the Conference objectives include:
Breath analysis Mobile apps & wearable sensors
Point of care diagnostics Wireless sensor applications
Implantable sensors Continuous monitoring
Sensors in drug development Personalised medicine
Detection of: metabolites; infectious diseases; cancer; etc
Lab to clinic: barriers to market entry
Papers on the Conference topics are being accepted as Oral or Poster presenta�ons - discounted fees for presenters and student posters
Get Involved Submit an Abstract - details here
Exhibit at the Conference - spaces for sensor companies and serv-ice providers; contact [email protected] for information
Join the Mailing List for Conference announcements
Optional Workshop - 27th March 2014Starting and Growing a Sensor CompanyWhat it feels like to start and grow a new sensor company. Leading experts explain: legal structure | finding the money | protecting IP | dealing with MHRA and FDA | people issues | being noticed in the crowd | who’s there to help etc.
Interested? Email Workshop to express interest.
XPRIZE and Nokia announced the 12 finalist teams for the first competition in the $2.25 million Nokia Sensing XCHALLENGE, two separate and consecutive competitions to advance innovative sens-ing technologies that capture meaningful data about a consumer’s health and surrounding environment. The advancements in sensing technology resulting from this competition will help lay the founda-tion for a mobile health revolution that transforms healthcare into a system that is highly personalized, instantly accessible and relevant to the medical needs of each individual. The 12 finalists who will now advance to the second round of the competition are:
apollo (Pittsburgh, Penn.) focused on developing the world’s smallest spectrometer-on-a-chip to detect personal vital and health signals non-in-vasively
ABUS-urodynamics (Asahikawa, Japan) an urodynamic study instrumentation group in the urologic surgery department of Asahikawa Medical University
Elfi-Tech (Rehovot, Israel) founded in 2006 to develop technology in the field of non-invasive monitoring of physiological parameters
Holomic (Los Angeles, Calif.) a team of experts in the medical device industry with spe-cific expertise in creating photonics-based technologies for mobile health applications
i-calQ (Salt Lake City, Utah) creating the world’s first smart phone-based quantitative point-of-care integrated diagnostic solution
Nokia X-Challenge Finalists
InSilixa (Sunnyvale, Calif.) a multidisciplinary, highly technical group focused on developing a hand-held, fully-integrated point-of-care DNA-based diagnos-tic tool
MoboSens (Urbana, Ill.) comprised of professors, scientists, engineers and graduate students from University of Illinois at Urbana-Champaign and National Center for Supercomputing Applications
Nanobiosym Health RADAR (Cambridge, Mass.)an advanced nanotech incubator and research institute
Owlstone (Cambridge, UK) a pioneer in the commercialization of state-of-the-art chemical detection systems
Programmable-Bio-Nano-Chip (Houston, Texas) a medical micro device research group from Rice University committed to improving the speed, accuracy and affordability of disease diagnosis
QUASAR (San Diego, Calif.)a world leader in noninvasive biosensing systems
Silicon BioDevices (Palo Alto, Calif.) a point-of-care diagnostics startup company formed to com-mercialize a novel sensor technology
The advancements in sensing technology resulting from this competi-tion will help lay the foundation for a mobile health revolution that transforms healthcare into a system that is highly personalized, in-stantly accessible and relevant to the medical needs of each individual.The full announcement and further information on the finalists can be read here
...Continued
COMSOL, multiphysics modelling software suppliers offer compli-mentary access to the 2012 COMSOL Conference User Presentations. The 2013 User Conference will be on October 23-25 in Rotterdam; call for papers here
The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018 according to a new market research report from SBWire
Brian Dolan reports in Mobile Health News “Frothy times for Google Glass in healthcare”. Not yet commercially available, and with a predicted price tag of $1500, it’s hard to say what Glass really threat-ens to disrupt in healthcare. It is clear, however, that many in healthcare are very excited to find out.
Alere™ MobileLink Receives FDA Clearance Alere™ Connect (an Alere Company) has been granted a 510(k) mar-ket clearance by the U.S. Food and Drug Administration for the Alere™ MobileLink. The new product offering is one of Alere’s connected de-vice technologies designed to empower patients by allowing self-testing at home and delivering data quickly and seamlessly to clinical systems accessed by their healthcare providers. Reported by Reuters.
Qualcomm and Rady Children’s Hospital San Diego Personal-ise Asthma Therapy for ChildrenQualcomm Life Inc and Rady Children’s Hospital have launched a research project in which a 3G enabled kit will be used to monitor the activities of asthmatic children, including the use of inhalers. The project features Asthmapolis and Zephyr technologies in order to help reduce costs and improve outcomes and seeks to determine whether asthma-related therapy can be personalized based on a pa-tient’s physiology, reducing serious asthmatic attacks, emergency room visits, hospitalization and associated costs. Read more...
Company News...
Gas Sensors Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018 A new market research report from Research and Markets features: City Technology, Figaro Engineering Inc, Membrapor AG, Dynament Ltd, and Alphasense
GlaxoSmithKline announced the launch of Action Potential Venture Capital (APVC) Limited, a new $50 million strategic venture capital fund that will invest in companies that pioneer bioelectronic medicines and technologies;. The fund has made its first investment in SetPoint Medical, developer of implantable device for treating inflammatory diseases. The field of bioelectronic medicines is in its very early stages. GSK’s ambition, through collaboration with scientists globally, is to have the first medicine that speaks the electrical language of our body ready for approval by the end of this decade.
Acreo Swedish ICT seeks commercial partners for low-cost printed biosensor The fully functional prototype developed uses electrically conductive materials as “inks” to print battery, sensor and displays which are integrated with flex electronic circuits. The next version will have all printed components integrated with a miniaturized chip, an integrated printed bio sensor. The enabling technology is developed at the research institute Acreo Swedish ICT in collaboration with The Biosensors and Bioelectronics center at Linköping University.For more information:Göran Gustafsson, Acreo Swedish ICT AB [email protected]
...Continued
First human tests of new biosensor that warns when athletes are about to ‘hit the wall’Professor Joseph Wang and col-leagues at UC San Diego have tested a new biosensor, applied to the human skin like a temporary tattoo, which can alert maratho-ners, competitive bikers and other “extreme” athletes that they’re about to “bonk,” or “hit the wall.” The sensor monitors lactate, a form of lactic acid released in sweat. “Electrochemical Tattoo Biosensors for Real-Time Noninvasive Lactate Monitoring in Human Perspiration” reported in Analytical Chemistry
ME biosensors show promise for pathogen detection on food surfacesPathogens can be detected on fresh food surfaces in real-time and in-situ thanks to a coil measurement technique demonstrated by re-searchers. Reported in Food Quality News
100 cyclists to trek across Europe decked out in wearable health monitors reported in Mobile Health NewsAs many as 100 riders will be pedaling for nearly two weeks from Brussels, Belgium, to Barcelona, Spain, in the first-ever mHealth Grand Tour, meant to highlight how mobile technologies can help fight diabe-tes. About 36 will be wearing Dexcom G5 continuous glucose moni-tors as well as Zephyr BioHarness sensors to capture their heart rate and other vital signs. Newcastle University Institute of Cellular Medicine’s MoveLab, a physical activity and exercise research center , will be collecting data during the tour for a clinical trial.
Technology News...
Three ways the cloud is revolutionizing life sciences Cloud computing and software-as-a-service (SaaS) IT models are revolutionizing most industry sectors around the world, and have had a profound impact on life sciences. Accenture Life Sciences have identified three major trends:1. More personalised medicine2. Better new product devlopment3. A global operating model
Read the full article
Smartphone platform shows promise as ‘artificial pancreas’ to control diabetes A three country research project lead by the University of Virginia’s Center for Diabetes Technology built a prototype system called Diabetes Assistant (DiAs) on modified Android phones, wirelessly connected to Dexcom monitors and Insulet OmniPod insulin pumps. They monitored a total of 20 patients with type 1 diabetes for 42-hour trials in ambulatory environments. The system worked well enough that it was designated as appropriate for outpatient use. Reported in Mobile Health News and first published in Diabetes Care
New Circulating Tumor Cell Isolation System For Early Cancer DetectionA microfluidic system for capturing circulating tumour cells (CTCs) in cancer patients has been developed at Peking University in China. CTC provide an index of the disease progress and its spread throughout the body. The device works by spatial gradation and can recover CTCs with a 90% efficiency. Read the article in Biomicrofluidics
...Continued
The UK Technology Strategy Board, a unit of the Department for Busi-ness, Industry and Skills, has announced that it will form a Diagnostics for Stratification Catapult.
UK Catapults are technology innovation centres modelled on Germa-ny’s Fraunhofer Centres. The intention is to form a network of world-leading technology and innovation centres which will help business transform ideas into new products and services. There are currently 7 such centres: high value manufacturing; cell therapy; off-shore renew-able energy; satellite applications; connected digital economy; future cities; transport systems.
Funding for the new centre will come from an additional £185m awarded to the TSB in the last spending review. The centre will look at developing diagnostics to be used within stratified medicine to identify patients for treatment. A TSB spokesman said that the catapult would “act as a rallying point to enable linkages between biopharma, diagnostics and healthcare systems,” and said that the catapult would help businesses tap into stratified medicine. A consultation exercise will begin later this year to assist in planning the new centre.
Stratified medicine is the concept of personalising medical care, so drug therapy is targetted at patients who will most beenfit. It requires links between biopharma and diagnostic companies, a need which is slowly being recognised but is to a large extent not yet in place.
Readers of Sensor100 will recall that we lead an effort in early 2012 to convince the TSB of a need for a Sensor Catapult, which was ulti-mately unsuccessful. Hopefully the new centre will acknowledge the place of bio-sensors in companion diagnostics.
Read about Catapult Centres...
Diagnostics for Stratification Catapult
Build your own sensor network:
Profile your organisation (it’s free): Directory
Subscribe to this Newsletter (it’s also free)
Promote your Event (free to list; fee for banner ads)See the 2013 and 2014 events calendarsPlease notify us of planned events
Advertise your products and services in this Newsletter and on our Expo page (for advertising rates email [email protected])
Sensor100 is a monthly newsletter published by:Captum Capital LimitedCumberland House35 Park RowNottingham NG1 6EEUnited Kingdom
About Sensor100
